• 9987 Citations
  • 42 h-Index
1991 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

Clinical prognostic model for older patients with advanced non-small cell lung cancer

Ganti, A. K., Wang, X., Stinchcombe, T. E., Wang, Y., Bradley, J., Cohen, H. J., Kelly, K., Paulus, R., Ramalingam, S. S., Vokes, E. E. & Pang, H., Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non–small-cell Lung Cancer

Owen, B., Gandara, D., Kelly, K., Moore, E., Shelton, D. & Knollmann, F., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

Research output: Contribution to journalArticle

Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non–small-cell Lung Cancer

Al-Obeidi, E., Li, T. & Kelly, K., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

Research output: Contribution to journalArticle

Efficacy and Safety of Avelumab for Patients with Recurrent or Refractory Ovarian Cancer: Phase 1b Results from the JAVELIN Solid Tumor Trial

Disis, M. L., Taylor, M. H., Kelly, K., Beck, J. T., Gordon, M., Moore, K. M., Patel, M. R., Chaves, J., Park, H., Mita, A. C., Hamilton, E. P., Annunziata, C. M., Grote, H. J., Von Heydebreck, A., Grewal, J., Chand, V. & Gulley, J. L., Jan 1 2019, (Accepted/In press) In : JAMA oncology.

Research output: Contribution to journalArticle

30 Scopus citations

Methods for the watch the spot trial: A pragmatic trial of more-versus less-intensive strategies for active surveillance of small pulmonary nodules

Watch the Spot Trial Investigators, Dec 1 2019, In : Annals of the American Thoracic Society. 16, 12, p. 1567-1576 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer: A Review

Abdel Karim, N. & Kelly, K., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalReview article

2 Scopus citations

Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer

Goldman, J. W., Waterhouse, D. M., George, B., O'Dwyer, P. J., Bhore, R., Banerjee, S., Lyons, L., Louis, C. U., Ong, T. J. & Kelly, K., Nov 26 2019, In : Frontiers in Oncology. 9, 1256.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

Langer, C. J., Redman, M. W., Wade, J. L., Aggarwal, C., Bradley, J. D., Crawford, J., Stella, P. J., Knapp, M. H., Miao, J., Minichiello, K., Herbst, R. S., Kelly, K., Gandara, D. R. & Papadimitrakopoulou, V. A., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

4 Scopus citations

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Edelman, M. J., Redman, M. W., Albain, K. S., McGary, E. C., Rafique, N. M., Petro, D., Waqar, S. N., Minichiello, K., Miao, J., Papadimitrakopoulou, V. A., Kelly, K., Gandara, D. R. & Herbst, R. S., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

4 Scopus citations

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Aggarwal, C., Redman, M. W., Lara, P. N., Borghaei, H., Hoffman, P., Bradley, J. D., Newman, A. J., Feldman, M. J., Minichiello, K., Miao, J., Mack, P. C., Papadimitrakopoulou, V. A., Herbst, R. S., Kelly, K. & Gandara, D. R., Jan 1 2019, In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

7 Scopus citations
2018

Abemaciclib in combination with single-agent options in patients with stage IV non–small cell lung cancer: A phase Ib study

Kim, E. S., Kelly, K., Paz-Ares, L. G., Garrido, P., Jalal, S., Mahadevan, D., Gutierrez, M., Provencio, M., Schaefer, E., Shaheen, M., Johnston, E. L., Kellie Turner, P., Kambhampati, S. R. P., Beckmann, R., Hossain, A., John, W. J. & Goldman, J. W., Nov 15 2018, In : Clinical Cancer Research. 24, 22, p. 5543-5551 9 p.

Research output: Contribution to journalArticle

4 Scopus citations

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

Liu, S. V., Groshen, S. G., Kelly, K., Reckamp, K. L., Belani, C., Synold, T. W., Goldkorn, A., Gitlitz, B. J., Cristea, M. C., Gong, I-Y., Semrad, T. J., Xu, Y., Xu, T., Koczywas, M., Gandara, D. R. & Newman, E. M., Jan 1 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

3 Scopus citations

Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC

Schild, S. E., Pang, H. H., Fan, W., Stinchcombe, T. E., Vokes, E. E., Ramalingam, S. S., Bradley, J. D., Kelly, K. & Wang, X., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

1 Scopus citations

First-in-human phase I, dose-escalation and -expansion study of telisotuzumab vedotin, an antibody–drug conjugate targeting c-Met, in patients with advanced solid tumors

Strickler, J. H., Weekes, C. D., Nemunaitis, J., Ramanathan, R. K., Heist, R. S., Morgensztern, D., Angevin, E., Bauer, T. M., Yue, H., Motwani, M., Parikh, A., Reilly, E. B., Afar, D., Naumovski, L. & Kelly, K., Nov 20 2018, In : Journal of Clinical Oncology. 36, 33, p. 3298-3306 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non–Small-cell Lung Cancer With Different Prognostic Significance

Iams, W. T., Yu, H., Shyr, Y., Patil, T., Horn, L., McCoach, C., Kelly, K., Doebele, R. C. & Camidge, D. R., Nov 1 2018, In : Clinical Lung Cancer. 19, 6, p. 531-543 13 p.

Research output: Contribution to journalArticle

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC

Goldberg, M. E., Montesion, M., Young, L., Suh, J., Greenbowe, J., Kennedy, M., Giaccone, G., Akerley, W. L., Dowlati, A., Creelan, B. C., Hicks, J. K., Hesketh, P. J., Kelly, K. L., Riess, J. W., Miller, V. A., Stephens, P. J., Frampton, G. M., Ali, S., Gregg, J. P. & Albacker, L. A., Nov 1 2018, In : PLoS One. 13, 11, e0208097.

Research output: Contribution to journalArticle

5 Scopus citations

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

Wang, Z., Aguilar, E. G., Luna, J. I., Dunai, C., Khuat, L. T., Le, C. T., Mirsoian, A., Minnar, C. M., Stoffel, K. M., Sturgill, I. R., Grossenbacher, S. K., Withers, S. S., Rebhun, R. B., Hartigan-O'Connor, D., Méndez-Lagares, G., Tarantal, A. F., Isseroff, R. R., Griffith, T. S., Schalper, K. A., Merleev, A. & 13 others, Saha, A., Maverakis, E. M., Kelly, K., Aljumaily, R., Ibrahimi, S., Mukherjee, S., Machiorlatti, M., Vesely, S. K., Longo, D. L., Blazar, B. R., Canter, R. J., Murphy, W. J. & Monjazeb, A. M., Jan 1 2018, (Accepted/In press) In : Nature Medicine.

Research output: Contribution to journalArticle

71 Scopus citations

Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure

Barbie, D. A., Spira, A., Kelly, K., Humeniuk, R., Kawashima, J., Kong, S. & Koczywas, M., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

Response to H. Nabi et al

Cheng, T. Y. D., Darke, A. K., Redman, M. W., Kelly, K., Santella, R. M., Albain, K. S. & Ambrosone, C. B., Dec 1 2018, In : Journal of the National Cancer Institute. 110, 12, p. 1424-1425 2 p.

Research output: Contribution to journalArticle

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

Kelly, K., Infante, J. R., Taylor, M. H., Patel, M. R., Wong, D. J., Iannotti, N., Mehnert, J. M., Loos, A. H., Koch, H., Speit, I. & Gulley, J. L., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

33 Scopus citations

Smoking, sex, and non–Small cell lung cancer: Steroid hormone receptors in tumor tissue (S0424)

Cheng, T. Y. D., Darke, A. K., Redman, M. W., Zirpoli, G. R., Davis, W., Ondracek, R. P., Bshara, W., Omilian, A. R., Kratzke, R., Reid, M. E., Molina, J. R., Kolesar, J. M., Chen, Y., MacRae, R. M., Moon, J., Mack, P., Gandara, D. R., Kelly, K., Santella, R. M., Albain, K. S. & 1 others, Ambrosone, C. B., Jan 1 2018, In : Journal of the National Cancer Institute. 110, 7, p. 734-742 9 p.

Research output: Contribution to journalArticle

4 Scopus citations
12 Scopus citations
4 Scopus citations

Tissue/site-agnostic study of ribociclib for tumors with cyclin D-CDK4/6 pathway genomic alterations: A Phase II, open-label, single-arm basket study

Peguero, J., Sohal, D. P. S., O'Neil, B. H., Safran, H., Kelly, K., Grilley-Olson, J. E., Subbiah, V., Nadauld, L., Purkayastha, D., Stealey, E., Ricart, A. D., Kang, B. P. & Eder, J. P., Jan 1 2018, In : JCO Precision Oncology. 2

Research output: Contribution to journalArticle

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non–Small Cell Lung Cancer

Schild, S. E., Fan, W., Stinchcombe, T. E., Vokes, E. E., Ramalingam, S. S., Bradley, J. D., Kelly, K., Pang, H. H. & Wang, X., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

1 Scopus citations

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Shukla, N. D., Salahudeen, A. A., Taylor, G. A., Ramalingam, S. S., Vokes, E. E., Goss, G. D., Decker, R. H., Kelly, K., Scagliotti, G. V., Mok, T. S. & Wakelee, H. A., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2017
4 Scopus citations

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer

Gandara, D. R., Leighl, N., Delord, J. P., Barlesi, F., Bennouna, J., Zalcman, G., Infante, J. R., Reckamp, K. L., Kelly, K., Shepherd, F. A., Mazieres, J., Janku, F., Gardner, O. S., Mookerjee, B., Wu, Y., Cox, D. S., Schramek, D., Peddareddigari, V., Liu, Y., D'Amelio, A. M. & 1 others, Blumenschein, G., Mar 1 2017, In : Journal of Thoracic Oncology. 12, 3, p. 556-566 11 p.

Research output: Contribution to journalArticle

12 Scopus citations

Avelumab, an anti-programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: Results from a multicenter, Phase Ib study

Apolo, A. B., Infante, J. R., Balmanoukian, A., Patel, M. R., Wang, D., Kelly, K., Mega, A. E., Britten, C. D., Ravaud, A., Mita, A. C., Safran, H., Stinchcombe, T. E., Srdanov, M., Gelb, A. B., Schlichting, M., Chin, K. & Gulley, J. L., Jul 1 2017, In : Journal of Clinical Oncology. 35, 19, p. 2117-2124 8 p.

Research output: Contribution to journalArticle

255 Scopus citations

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): Dose-expansion cohort of a multicentre, open-label, phase 1b trial

Gulley, J. L., Rajan, A., Spigel, D. R., Iannotti, N., Chandler, J., Wong, D. J. L., Leach, J., Edenfield, W. J., Wang, D., Grote, H. J., Heydebreck, A. V., Chin, K., Cuillerot, J. M. & Kelly, K., 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

152 Scopus citations

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): A randomised, phase 3 study

Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T., Bazhenova, L., Masters, G., Oettel, K., Guaglianone, P., Reynolds, C., Karnad, A., Arnold, S. M., Varella-Garcia, M., Moon, J., Mack, P., Blanke, C. D., Hirsch, F. R., Kelly, K. & Gandara, D. R., Jan 1 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

24 Scopus citations

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry

Lara, J. D., Brunson, A., Riess, J., Kelly, K., Lara, P. N. & Gandara, D. R., Oct 1 2017, In : Lung Cancer. 112, p. 165-168 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

Effects of imputation on correlation: Implications for analysis of mass spectrometry data from multiple biological matrices

Taylor, S. L., Renee Ruhaak, L., Kelly, K., Weiss, R. H. & Kim, K., 2017, In : Briefings in Bioinformatics. 18, 2, p. 312-320 9 p.

Research output: Contribution to journalArticle

12 Scopus citations
2 Scopus citations
19 Scopus citations

Infusion-related reactions with administration of avelumab: Mild and manageable side effects

Gulley, J. L. & Kelly, K., Oct 1 2017, In : Translational Cancer Research. 6, p. S1296-S1298

Research output: Contribution to journalLetter

1 Scopus citations

Multivariate two-part statistics for analysis of correlated mass spectrometry data from multiple biological specimens

Taylor, S. L., Ruhaak, L. R., Weiss, R. H., Kelly, K. & Kim, K., 2017, In : Bioinformatics. 33, 1, p. 17-25 9 p.

Research output: Contribution to journalArticle

2 Scopus citations

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials

West, H. L., Moon, J., Wozniak, A. J., Mack, P., Hirsch, F. R., Bury, M. J., Kwong, M., Nguyen, D. D., Moore, D. F., Miao, J., Redman, M., Kelly, K. & Gandara, D. R., 2017, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)

Tsao, A. S., Moon, J., Wistuba, I. I., Vogelzang, N. J., Kalemkerian, G. P., Redman, M. W., Gandara, D. R. & Kelly, K., Aug 1 2017, In : Journal of Thoracic Oncology. 12, 8, p. 1299-1308 10 p.

Research output: Contribution to journalArticle

13 Scopus citations

Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US national cancer institute cooperative group studies

Stinchcombe, T. E., Zhang, Y., Vokes, E. E., Schiller, J. H., Bradley, J. D., Kelly, K., Curran, W. J., Schild, S. E., Movsas, B., Clamon, G., Govindan, R., Blumenschein, G. R., Socinski, M. A., Ready, N. E., Akerley, W. L., Cohen, H. J., Pang, H. H. & Wang, X., Sep 1 2017, In : Journal of Clinical Oncology. 35, 25, p. 2885-2892 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: A single-arm, phase 2 study

Chen, A. M., Felix, C., Wang, P. C., Hsu, S., Basehart, V., Garst, J., Beron, P., Wong, D., Rosove, M. H., Rao, S., Melanson, H., Kim, E., Palmer, D., Qi, L., Kelly, K., Steinberg, M. L., Kupelian, P. A. & Daly, M. E., 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

100 Scopus citations

The Ever-Increasing Number of Trial Eligibility Criteria: Time to Bend the Curve

Bradley, J., Kelly, K. & Stinchcombe, T. E., Oct 1 2017, In : Journal of Thoracic Oncology. 12, 10, p. 1459-1460 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non–Small Cell Lung Cancer

David, E. A., Clark, J. M., Cooke, D. T., Melnikow, J., Kelly, K. & Canter, R. J., Nov 1 2017, In : Journal of Thoracic Oncology. 12, 11, p. 1636-1645 10 p.

Research output: Contribution to journalReview article

23 Scopus citations

Treatment of Locally Advanced Non–Small Cell Lung Cancer

Tam, K., Daly, M. E. & Kelly, K., Feb 1 2017, In : Hematology/Oncology Clinics of North America. 31, 1, p. 45-57 13 p.

Research output: Contribution to journalReview article

5 Scopus citations
2016

Impact study: MK-0646 (Dalotuzumab), insulin growth factor 1 receptor antibody combined with pemetrexed and cisplatin in stage IV metastatic non-squamous lung cancer

Huang, C. H., Williamson, S. K., Neupane, P., Taylor, S. A., Allen, A., Smart, N. J., Uypeckcuat, A. M., Spencer, S., Wick, J., Smith, H., Van Veldhuizen, P. J. & Kelly, K., 2016, In : Frontiers in Oncology. 5, JAN, 301.

Research output: Contribution to journalArticle

1 Scopus citations

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer

Lara, M. S., Holland, W. S., Chinn, D., Burich, R. A., Lara, P. N., Gandara, D. R., Kelly, K. & Mack, P., Mar 22 2016, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

13 Scopus citations

Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer

Mall, C., Sckisel, G. D., Proia, D. A., Mirsoian, A., Grossenbacher, S. K., Pai, C. C. S., Chen, M., Monjazeb, A. M., Kelly, K., Blazar, B. R. & Murphy, W. J., Feb 1 2016, In : OncoImmunology. 5, 2

Research output: Contribution to journalArticle

14 Scopus citations

Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer

Fahrmann, J. F., Grapov, D., Defelice, B. C., Taylor, S., Kim, K., Kelly, K., Wikoff, W. R., Pass, H., Rom, W. N., Fiehn, O. & Miyamoto, S., Apr 13 2016, In : Cancer Biomarkers. 16, 4, p. 609-617 9 p.

Research output: Contribution to journalArticle

20 Scopus citations

The international association for the study of lung cancer consensus statement on optimizing management of EGFR mutation-positive non-small cell lung cancer: Status in 2016

Tan, D. S. W., Yom, S. S., Tsao, M. S., Pass, H. I., Kelly, K., Peled, N., Yung, R. C., Wistuba, I. I., Yatabe, Y., Unger, M., Mack, P., Wynes, M. W., Mitsudomi, T., Weder, W., Yankelevitz, D., Herbst, R. S., Gandara, D. R., Carbone, D. P., Bunn, P. A., Mok, T. S. K. & 1 others, Hirsch, F. R., 2016, In : Journal of Thoracic Oncology. 11, 7, p. 946-963 18 p.

Research output: Contribution to journalReview article

114 Scopus citations